Factorial design for randomized clinical trials

被引：7

作者：

Bria, E. ^{[1
]}

Di Maio, M.

Nistico, C.

Cuppone, F.

Terzoli, E.

Cognetti, F.

Giannarelli, D.

机构：

[1] Regina Elena Inst Canc Res, Dept Med Oncol, Rome, Italy

[2] Natl Canc Inst, Naples, Italy

[3] Regina Elena Inst Canc Res, Rome, Italy

来源：

ANNALS OF ONCOLOGY | 2006年 / 17卷 / 10期

关键词：

D O I：

10.1093/annonc/mdl106

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：1607 / 1608

页数：2

相关论文

共 9 条

[1] Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741 [J].

Citron, ML ;

Berry, DA ;

Cirrincione, C ;

Hudis, C ;

Winer, EP ;

Gradishar, WJ ;

Davidson, NE ;

Martino, S ;

Livingston, R ;

Ingle, JN ;

Perez, EA ;

Carpenter, J ;

Hurd, D ;

Holland, JF ;

Smith, BL ;

Sartor, CI ;

Leung, EH ;

Abrams, J ;

Schilsky, RL ;

Muss, HB ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1431-1439

[2] Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks [J].

Green, MC ;

Buzdar, AU ;

Smith, T ;

Ibrahim, NK ;

Valero, V ;

Rosales, MF ;

Cristofanilli, M ;

Booser, DJ ;

Pusztai, L ;

Rivera, E ;

Theriault, RL ;

Carter, C ;

Frye, D ;

Hunt, KK ;

Symmans, WF ;

Strom, EA ;

Sahin, AA ;

Sikov, W ;

Hortobagyi, GN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5983-5992

[3] Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer [J].

Jones, SE ;

Erban, J ;

Overmoyer, B ;

Budd, GT ;

Hutchins, L ;

Lower, E ;

Laufman, L ;

Sundaram, S ;

Urba, WJ ;

Pritchard, KI ;

Mennel, R ;

Richards, D ;

Olsen, S ;

Meyers, ML ;

Ravdin, PM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5542-5551

[4] Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells [J].

Pasquier, E ;

Honore, S ;

Pourroy, B ;

Jordan, MA ;

Lehmann, M ;

Briand, C ;

Braguer, D .

CANCER RESEARCH, 2005, 65 (06) :2433-2440

[5]

Seidman AD, 2004, J CLIN ONCOL, V22, p6S

[6] Will weekly work? Seems to be so ... [J].

Seidman, AD .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5873-5874

[7]

SPARANO JA, 2005, P SAN ANT BREAST CAN

[8] Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: Clinical implications [J].

Taghian, AG ;

Abi-Raad, R ;

Assaad, SI ;

Casty, A ;

Ancukiewicz, M ;

Yeh, E ;

Molokhia, P ;

Attia, K ;

Sullivan, T ;

Kuter, I ;

Boucher, Y ;

Powell, SN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1951-1961

[9] Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: Cancer and Leukemia Group B Trial 9342 [J].

Winer, EP ;

Berry, DA ;

Woolf, S ;

Duggan, W ;

Kornblith, A ;

Harris, LN ;

Michaelson, RA ;

Kirshner, JA ;

Fleming, GF ;

Perry, MC ;

Graham, ML ;

Sharp, SA ;

Keresztes, R ;

Henderson, CI ;

Hudis, C ;

Muss, H ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2061-2068